50 likes | 58 Views
The latest report by Precision Business Insights, titled u201cLiquid Biopsy Marketu201d covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.
E N D
Market Overview: The global liquid biopsy market size was valued at USD 4.4 billion in 2021 and is expected to reach a value of USD x million by 2028, growing at a CAGR of 18.2% during the forecast period 2022 to 2028. The liquid biopsy market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of the liquid biopsy market analysis from 2022 to 2028 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description 2
Market Segments: The liquid biopsy market has been fragmented based on: 1. By Product Type: Consumables, Instruments. 2. By End User: Hospitals, Diagnostic Laboratories, Academic and Research Centers Others. 3. By Geography: North America, Asia Pacific, Europe, Middle East, and Africa, Latin America Request Sample Report 3
Key Players: Some of the major key players in the liquid biopsy market are: Marathon Pharmaceuticals, LLC ITALFARMACO S.p.A. FibroGen, Inc. Summit Therapeutics plc PTC Therapeutics Santhera Pharmaceuticals Sarepta Therapeutics, Inc. Request Sample Report 4
Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553 5